Literature DB >> 3134229

Marked increase of Pseudomonas aeruginosa serotype 012 in Belgium since 1982.

D Allemeersch1, J Beumer, M Devleeschouwer, S De Maeyer, J Dony, C Godard, P Osterrieth, A Pithsy, P Van der Auwera, H Van Poppel.   

Abstract

Routine typing was performed on a total of 7089 Pseudomonas aeruginosa strains isolated in 16 Belgian hospitals in the period from 1977 to 1986. The annual number of strains received ranged from 318 to 1346. The incidence of serotype O:12 was less than 2% until 1981 when it rose to 4%, steadily increasing to become the predominant serotype in 1984 (22%), 1985 (18%) and 1986 (22%). Since 1980 the O:12 isolates have exhibited characteristic patterns on pyocin and phage typing, 89% of O:12 isolates belonging to pyocin types 1, 39, 43, 45 or 105, whereas only 51% of isolates of other serotypes belonged to those pyocin types. Ninety-three per cent of serotype O:12 isolates belonged to phage types 68/119x, 68 or 119x, or were non-typable, whereas only 24.37% of other serotypes isolates exhibited these phage patterns. These distinctive patterns of pyocin and phage types suggest a high degree of homogeneity within the O:12 strains isolated in recent years in Belgium. Multi-centre or country-wide survey of Pseudomonas aeruginosa strains isolated in hospitals using epidemiological markers may be of value in identifying a sudden increase in epidemic strains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134229     DOI: 10.1007/bf01963099

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains.

Authors:  M Del Piano; P La Palombara; A Picci; R Nicosia
Journal:  Microbiologica       Date:  1986-04

2.  Epidemiological markers for Pseudomonas aeruginosa. 3. Comparison of bacteriophage typing, serogrouping, and pyocine typing on a heterogeneous clinical material.

Authors:  T Bergan
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-02

3.  Typing of Pseudomonas pyocyanea by pyocine production.

Authors:  R R Gillies; J R Govan
Journal:  J Pathol Bacteriol       Date:  1966-04

Review 4.  State of the art: typing Pseudomonas aeruginosa.

Authors:  T L Pitt
Journal:  J Hosp Infect       Date:  1980-09       Impact factor: 3.926

5.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

6.  [Evaluation of biochemical, serological and antibiotic-sensitivity characteristics of Pseudomonas aeruginosa for epidemiological purpose].

Authors:  V Chiaradia; M Crovatto; G Marchetti; E Basaglia; G Santini; E Grattoni
Journal:  Ann Sclavo       Date:  1982 Mar-Apr

7.  Further studies in the pyocine typing of Pseudomonas pyocyanea.

Authors:  J R Govan; R R Gillies
Journal:  J Med Microbiol       Date:  1969-02       Impact factor: 2.472

8.  [Epidemiology of Pseudomonas aeruginosa hospital infection in the Ivory Coast].

Authors:  M Dosso; J F Vieu; N Wagta; B Klein
Journal:  Bull Soc Pathol Exot Filiales       Date:  1987

9.  The in vitro activity of ceftazidime against a multi-resistant serotype 12 Pseudomonas aeruginosa.

Authors:  G Ninane; P B Harper
Journal:  Infection       Date:  1983       Impact factor: 3.553

10.  [Is there a geographic epidemiology of serogroups O of Pseudomonas aeruginosa?].

Authors:  J F Vieu; G Allos; B Hassan-Massoud; M O Santos-Ferreira; G Tselentis
Journal:  Bull Soc Pathol Exot Filiales       Date:  1984 May-Jun
View more
  9 in total

1.  Study of Pseudomonas aeruginosa serotype O12 isolates with a common antibiotic susceptibility pattern.

Authors:  A Talarmin; P Dubrous; P Gérome; Y Buisson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

2.  Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections.

Authors:  P Visca; F Chiarini; A Mansi; C Vetriani; L Serino; N Orsi
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

3.  Epidemiology of community-acquired Pseudomonas aeruginosa infections in children.

Authors:  I Paraskaki; E Lebessi; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

4.  Multiresistant serotype O 12 Pseudomonas aeruginosa: evidence for a common strain in Europe.

Authors:  T L Pitt; D M Livermore; D Pitcher; A C Vatopoulos; N J Legakis
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

5.  lfnA from Pseudomonas aeruginosa O12 and wbuX from Escherichia coli O145 encode membrane-associated proteins and are required for expression of 2,6-dideoxy-2-acetamidino-L-galactose in lipopolysaccharide O antigen.

Authors:  Jerry D King; Erin F Mulrooney; Evgeny Vinogradov; Bernd Kneidinger; Kristen Mead; Joseph S Lam
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

6.  Survey of susceptibility to selected antibiotics of Pseudomonas aeruginosa strains isolated from patients with tumor disease and their relationship to serotype.

Authors:  B Zatkovic; J Trupl; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

7.  Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa.

Authors:  A Tsakris; A C Vatopoulos; L S Tzouvelekis; N J Legakis
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

8.  The Widespread Multidrug-Resistant Serotype O12 Pseudomonas aeruginosa Clone Emerged through Concomitant Horizontal Transfer of Serotype Antigen and Antibiotic Resistance Gene Clusters.

Authors:  Sandra Wingaard Thrane; Véronique L Taylor; Luca Freschi; Irena Kukavica-Ibrulj; Brian Boyle; Jérôme Laroche; Jean-Paul Pirnay; Roger C Lévesque; Joseph S Lam; Lars Jelsbak
Journal:  MBio       Date:  2015-09-22       Impact factor: 7.867

9.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.